Bellevue Funds (Lux) Bellevue Healthcare Strategy I2 EURRegístrese para Ver el Rating |
Cómo se ha comportado este fondo | 30/04/2024 |
Crecimiento de 1.000 (EUR) | Gráfico Avanzado |
Fondo | 17,7 | 14,7 | -5,5 | -6,0 | 3,6 | |
+/-Cat | 6,5 | -2,0 | 4,3 | -5,2 | 0,2 | |
+/-Ind | - | -11,3 | -5,6 | -5,8 | -2,7 | |
Categoría: RV Sector Salud | ||||||
Benchmark de la Categoría: Morningstar Gbl Health TME ... |
Estadística Rápida | ||
VL 08/05/2024 | EUR 219,47 | |
Cambio del día | -0,30% | |
Categoría Morningstar™ | RV Sector Salud | |
ISIN | LU1587979334 | |
Patrimonio (Mil) 08/05/2024 | USD 425,36 | |
Patrimonio Clase (Mil) - | - | |
Comisión Máx. Suscripción | 5,00% | |
Gastos Corrientes 31/01/2024 | 1,20% |
Objetivo de inversión: Bellevue Funds (Lux) Bellevue Healthcare Strategy I2 EUR |
The Sub-fund is an actively managed equity fund. It is based on the Bellevue Healthcare Strategy that has been in existence since 2007. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two-thirds of the net assets of Bellevue Healthcare Strategy in a portfolio of carefully chosen shares and other equity securities of companies in the healthcare industry, or companies whose main activity consists of holding shares in such companies or financing such companies and who have their registered office or carry out the majority of their economic activity in recognised countries. |
Returns | |||||||||||||
|
Gestión | ||
Nombre del gestor Fecha Inicio | ||
Samuel Stursberg 31/10/2016 | ||
Zahide Donat 31/10/2016 | ||
Creación del fondo 31/03/2017 |
Anuncio publicitario |
Benchmark de la Categoría | |
Benchmark de fondos | Benchmark Morningstar |
MSCI World/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Qué posee el fondo Bellevue Funds (Lux) Bellevue Healthcare Strategy I2 EUR | 31/03/2024 |
|
|
5 mayores posic. | Sector | % |
Intuitive Surgical Inc | Salud | 4,55 |
Boston Scientific Corp | Salud | 4,26 |
Merck & Co Inc | Salud | 4,15 |
Eli Lilly and Co | Salud | 4,11 |
Cencora Inc | Salud | 3,99 |
Incremento Reducción Nuevo desde la anterior cartera | ||
Bellevue Funds (Lux) Bellevue Healthcare Strategy I2 EUR |